Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
First regulatory submission completed for CHIKV VLP seeking approval of the vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older Represents first BLA for a chikungunya vaccine for adolescents …